NCT02717091 2020-09-10Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic CancerNagoya UniversityPhase 2 Unknown50 enrolled
NCT03850769 2020-03-10Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic CancerPeking Union Medical College HospitalPhase 2 Unknown60 enrolled